IRIS
VECCHIO, GIANCARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.460
NA - Nord America 7.602
AS - Asia 6.411
SA - Sud America 896
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 165
OC - Oceania 6
Totale 34.719
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.186
US - Stati Uniti d'America 7.313
SG - Singapore 3.161
RU - Federazione Russa 1.936
CN - Cina 1.111
NL - Olanda 934
VN - Vietnam 811
BR - Brasile 734
HK - Hong Kong 597
FR - Francia 445
DE - Germania 389
SE - Svezia 336
FI - Finlandia 294
UA - Ucraina 221
GB - Regno Unito 186
IE - Irlanda 184
CA - Canada 167
IN - India 133
BD - Bangladesh 108
JP - Giappone 88
IQ - Iraq 67
PL - Polonia 64
ZA - Sudafrica 58
ES - Italia 55
MX - Messico 48
AR - Argentina 47
TR - Turchia 46
EC - Ecuador 34
AL - Albania 32
CH - Svizzera 31
PK - Pakistan 27
IL - Israele 26
ID - Indonesia 23
CI - Costa d'Avorio 20
PH - Filippine 20
TH - Thailandia 19
VE - Venezuela 18
BG - Bulgaria 17
KR - Corea 17
RO - Romania 17
IR - Iran 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
AT - Austria 15
BE - Belgio 15
CO - Colombia 15
SA - Arabia Saudita 14
TW - Taiwan 14
CL - Cile 13
LT - Lituania 13
UY - Uruguay 13
DZ - Algeria 12
CR - Costa Rica 11
GR - Grecia 11
JM - Giamaica 11
JO - Giordania 11
KE - Kenya 11
TN - Tunisia 11
NI - Nicaragua 10
PY - Paraguay 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
DK - Danimarca 9
MA - Marocco 9
MY - Malesia 9
NP - Nepal 9
PE - Perù 8
PT - Portogallo 8
EE - Estonia 7
OM - Oman 7
BB - Barbados 6
HU - Ungheria 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
DO - Repubblica Dominicana 5
EG - Egitto 5
EU - Europa 5
KZ - Kazakistan 5
NG - Nigeria 5
RS - Serbia 5
SC - Seychelles 5
SI - Slovenia 5
AU - Australia 4
HN - Honduras 4
HR - Croazia 4
LK - Sri Lanka 4
MD - Moldavia 4
SM - San Marino 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
BO - Bolivia 3
BY - Bielorussia 3
CW - ???statistics.table.value.countryCode.CW??? 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
LB - Libano 3
LU - Lussemburgo 3
LY - Libia 3
PA - Panama 3
Totale 34.486
Salva come PNG Salva come JPEG
Città #
Singapore 1.309
Rome 1.021
San Jose 956
Naples 763
Milan 749
Ashburn 630
Hong Kong 572
Moscow 537
Chandler 464
Jacksonville 365
Council Bluffs 309
Florence 253
Millbury 244
Turin 240
Beijing 239
Princeton 236
Ho Chi Minh City 230
Bologna 218
Santa Clara 209
Palermo 207
Lauterbourg 199
The Dalles 194
Phoenix 186
Hanoi 177
Nanjing 176
Los Angeles 159
Bari 157
Wilmington 139
Catania 129
Buffalo 124
Padova 119
Boston 115
Amsterdam 109
Napoli 89
Nanchang 84
New York 75
Tokyo 75
Dallas 74
Perugia 74
Brescia 73
Pescara 73
Houston 70
Verona 68
Kronberg 67
São Paulo 67
Parma 64
Genoa 60
Ottawa 59
Messina 57
Munich 57
Salerno 57
Trieste 57
Cagliari 55
Frankfurt am Main 53
Pisa 51
Haiphong 46
Boardman 44
Redondo Beach 44
Reggio Emilia 44
Modena 43
Falls Church 41
Venice 41
Pavia 40
Kunming 39
Shenyang 37
Monza 35
Norwalk 35
Orem 35
Ann Arbor 33
Treviso 32
Turku 32
Caserta 31
Tianjin 31
Montreal 30
Seattle 30
Ancona 28
Baghdad 28
Chicago 28
Lucca 28
Bergamo 27
Brooklyn 27
Da Nang 27
Ferrara 27
Toronto 27
Atlanta 25
Denver 25
Johannesburg 25
Reggio Calabria 25
Changsha 24
Hebei 24
Jiaxing 24
Stockholm 24
Vicenza 24
Warsaw 24
Chennai 23
Hefei 23
Afragola 22
Helsinki 22
London 22
Avellino 21
Totale 14.560
Salva come PNG Salva come JPEG
Nome #
La cascata delle MAPK come bersaglio terapeutico per i carcinomi della tiroide. 15.456
Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer 170
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 162
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 162
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 156
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 156
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 156
[On the transport of thyroxine by the serum proteins of the Ammocoete of Petromyzon planeri Bl.] 155
Patologia Generale 153
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer 152
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B 147
Antitumor pancreatic-type RNases 146
ONYX-015, an E1B gene-defective adenovirus,induces cell death in human anaplastic thyroid carcinoma cell lines. 145
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati 145
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases 142
Human papilloma virus 16E7 oncogene does not cooperate with ret/ptc 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice 138
Transformation of differentiated rat thyroid epithelial cells by viral and cellular oncogenes 138
Different mutations of the RET gene cause different human tumoral diseases. 137
Nino Salvatore tenth anniversary memorial meeting:thyroid and beyond 137
Molecular mechanisms of RET activation in human cancer 135
A dimeric mutant of human pancreas ribonuclease with selective antitumor action 134
Fissazione degli ormoni tiroidei al micrococcus lysodeikticus 131
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. 130
Ret-mediated mitogenesis requires Src kinase activity. 130
Constitutive expression of transforming growth factor alpha does not transform rat thyroid epithelial cells. 130
DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS 129
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. 128
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. 127
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis 125
Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin 125
Recent advances in understanding immune phenotypes of thyroid carcinomas: Prognostication and emerging therapies [version 1; referees: 2 approved] 124
H4(D10S170),a gene frequently rearranged with RET in papillary thyroid carcinomas:functional characterization. 122
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. 122
Onyx-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells 122
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE 122
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. 122
Signaling through ras is essential for ret oncogene induced cell differentiation in PC12 cells 121
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. 121
TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line 121
Studies of some immunological properties of thyroid iodoproteins 121
Espressione dei genomi virali in cellule infettate da MSV e da MuLV 121
Polyribosomes from rat thyroid gland 120
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma 119
Activation of RET oncogene and thyroid carcinogenesis 119
In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors. 117
[On the extracellular localization of the iodide compartment: distribution of I-131 labelled NaI and of Na22 labelled NaCl in the mouse bearing an ascites tumor (Ehrlich's adenocarcinoma).] 117
RET 116
Post-translational modification by sumoylation and ubiquitinylation of H4 (D10S170), the product of first and most frequently observed RET-fused gene 111
Different mutations of the RET gene cause different human tumoral diseases. 110
Effetti di una sostanza ad azione anti-tiroidea,l'1- metil-2 -mercapto-imidazolo(tapazolo) sulla iodazione e la biosintesi delle iodoproteine tiroidee di ratto 108
Seminal ribonuclease inhibits tumor growth and reduces the metastatic potential of Lewis lung carcinoma. 107
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells. 107
[On the fixation of thyroid hormones by the isolated cells of Ehrlich's adenocarcinoma (ascites tumor).] 107
Aspetti strutturali e fuzionali delle iodoproteine tiroidee 107
Development of thyroid papillary carcinomas secondary to tissue specific expression of the RET/PTC1 oncogene in transgenic mice 106
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 106
Changes in cellular gene expression in rat thyroid epithelial cells transformed by the Kirsten murine sarcoma virus. 106
European Thyroid Association: 2006 in Naples. 105
[ON THE DISTRIBUTION OF 3,5,3'-TRIIODO-L-THYRONINE (T3) AND L-THYROXINE (T4) IN THE TISSUE OF MICE BEARING ASCITES TUMOR (EHRLICH'S ADENOCARCINOMA).] 103
45th Annual Meeting of the Italian Cancer Society 102
Nino Salvatore's contribution to scientific collaboration between Europe and the US in endocrinology. 102
Oncologia ed Endocrinologia Molecolare. 102
On the dissociation of human thyroglobulin by ultraviolet irradiation 102
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. 102
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). 101
Verapamil reverts resistance to drug-induced apoptosis in Ki-ras-transformed cells by altering the cell membrane and the mitochondrial transmembrane potentials. 101
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. 100
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC. 100
Patologia Generale 99
The Kirsten murine sarcoma virus induces rat thyroid carcinomas in vivo 98
RET\PTC activation in human thyroid carcinomas 98
The PTC oncogene is able to dedifferentiate a rat thyroid epithelial cell line in culture 97
Biosynthesis of thyroglobulin: Partial characterization of a labeled 6 S precursor 96
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. 96
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells 95
Preferential expression of the dbl protooncogene in some tumors of neuroectodermal origin. 95
Molecular mechanisms of RET activation in human neoplasia 93
Activation of RET as a dominant transforming gene by germline mutatios of MEN2A and MEN2B 93
PRODUCTION OF TRANSGENIC MICE EXPRESSING THE KI-RAS ONCOGENE UNDER THE CONTROL OF A THYROGLOBULIN PROMOTER 93
Presence of physiologically stimulated RET in adult rat brain: induction of RET expression during nerve regeneration. 93
Effetti dell'interferone sulll'espressione del genoma dell'FLV nelle cellule eritroleucemiche di Friend 93
Molecular mechanisms of RET activation in human cancer. 93
VII Meeting of molecular oncology 92
Molecular mechanisms of RET activation in human neoplasia. 92
Oncogenes of DNA and RNA tumor viruses and the origin of cellular oncogenes. 91
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. 90
Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus. 90
Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment. 88
CHARACTERIZATION OF AN INVERSION ON THE LONG ARM OF CHROMOSOME-10 JUXTAPOSING D10S170 AND RET AND CREATING THE ONCOGENIC SEQUENCE RET PTC 86
Virus-specific rna and viral proteins in polyribosomesof cells transformed by the murine sarcoma-leukemia virus:Analysis by molecular hibridation immunoprecipitation and polyacrylamide gel electrophoresis 86
Molecular mechanisms of Ret activation in human neoplasia 85
Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture 85
A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. 85
27S THYROID IODOPROTEIN. ISOLATION AND PROPERTIES. 85
Identification of a chimeric gene frequently activated in human thyroid papillary carcinomas 84
The cooperation between viral ras genes and different immortalizing genes induces the transformation of rat thyroid epithelial cells 84
Molecular cloning of PTC,a new oncogene found activated in human thyiroid papillary carcinomas and their lymph node metastates 83
Epidemiologia dei tumori umani 82
The ETA meets in Sweden 82
Biosynthesis of thyroid iodoproteins in vivo and in tissue slices. 82
Totale 26.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.152 0 0 0 0 105 186 193 194 262 182 357 673
2022/20233.984 322 145 155 292 351 380 391 406 400 319 382 441
2023/20244.984 274 323 478 337 371 374 726 527 223 293 581 477
2024/20258.590 720 660 405 383 416 513 1.011 653 797 686 1.693 653
2025/20269.420 1.154 605 947 940 1.664 480 947 621 1.085 470 244 263
2026/20271.666 202 233 439 746 46 0 0 0 0 0 0 0
Totale 34.719